Pulmonx Corp (LUNG) stock
LUNGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/3044% below fair value
$2.73−0.06 (-2.32%)
Close on Nov 17, 2026Market cap $117.46MP/E –Yield –
Pulmonx operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Pulmonx's operating cash flow for the twelve months ending Jun 30, 2026 was -$30.56M. For fiscal 2025 it was -$32.38M. The highest annual figure on record is -$18.39M in fiscal 2018.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$32.38M | – |
| FY2024 | Dec 31, 2024 | -$31.54M | – |
| FY2023 | Dec 31, 2023 | -$37.61M | – |
| FY2022 | Dec 31, 2022 | -$45.08M | – |
| FY2021 | Dec 31, 2021 | -$41.39M | – |
| FY2020 | Dec 31, 2020 | -$30.63M | – |
| FY2019 | Dec 31, 2019 | -$20.77M | – |
| FY2018 | Dec 31, 2018 | -$18.39M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$5.21M | – |
| Q1 FY2026 | Mar 31, 2026 | -$10.10M | – |
| Q4 FY2025 | Dec 31, 2025 | -$7.08M | – |
| Q3 FY2025 | Sep 30, 2025 | -$8.16M | – |
| Q2 FY2025 | Jun 30, 2025 | -$3.91M | – |
| Q1 FY2025 | Mar 31, 2025 | -$13.22M | – |
| Q4 FY2024 | Dec 31, 2024 | -$6.73M | – |
| Q3 FY2024 | Sep 30, 2024 | -$7.24M | – |
| Q2 FY2024 | Jun 30, 2024 | -$5.77M | – |
| Q1 FY2024 | Mar 31, 2024 | -$11.80M | – |
| Q4 FY2023 | Dec 31, 2023 | -$8.45M | – |
| Q3 FY2023 | Sep 30, 2023 | -$8.63M | – |
| Q2 FY2023 | Jun 30, 2023 | -$7.89M | – |
| Q1 FY2023 | Mar 31, 2023 | -$12.64M | – |
| Q4 FY2022 | Dec 31, 2022 | -$9.81M | – |
| Q3 FY2022 | Sep 30, 2022 | -$10.69M | – |
| Q2 FY2022 | Jun 30, 2022 | -$9.56M | – |
| Q1 FY2022 | Mar 31, 2022 | -$15.03M | – |
| Q4 FY2021 | Dec 31, 2021 | -$10.71M | – |
| Q3 FY2021 | Sep 30, 2021 | -$8.32M | – |
| Q2 FY2021 | Jun 30, 2021 | -$12.69M | – |
| Q1 FY2021 | Mar 31, 2021 | -$9.67M | – |
| Q4 FY2020 | Dec 31, 2020 | -$7.26M | – |
| Q3 FY2020 | Sep 30, 2020 | -$5.83M | – |
| Q2 FY2020 | Jun 30, 2020 | -$7.69M | – |
| Q1 FY2020 | Mar 31, 2020 | -$9.85M | – |
| Q4 FY2019 | Dec 31, 2019 | -$3.47M | – |
See a number that looks wrong?